VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 137 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $2,362,000 | -7.3% | 128,346 | +31.6% | 0.53% | -14.6% |
| Q4 2018 | $2,548,000 | -18.3% | 97,521 | -40.4% | 0.62% | +2.3% |
| Q2 2018 | $3,117,000 | +8.3% | 163,626 | -4.2% | 0.60% | +12.7% |
| Q1 2018 | $2,879,000 | -6.3% | 170,834 | -15.5% | 0.54% | -16.1% |
| Q4 2017 | $3,074,000 | +8.9% | 202,230 | +28.2% | 0.64% | -18.9% |
| Q3 2017 | $2,824,000 | +14.6% | 157,781 | -10.4% | 0.79% | +27.8% |
| Q1 2017 | $2,465,000 | – | 176,056 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
| Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
| Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
| Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
| EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
| Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
| EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
| UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
| ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
| 361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |